Joseph C. Sardano Sells 12,192 Shares of Sensus Healthcare, Inc. (SRTS) Stock
Sensus Healthcare, Inc. (NASDAQ:SRTS) CEO Joseph C. Sardano sold 12,192 shares of the business’s stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $6.00, for a total value of $73,152.00. Following the sale, the chief executive officer now directly owns 1,605,751 shares of the company’s stock, valued at approximately $9,634,506. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Shares of Sensus Healthcare, Inc. (SRTS) traded up 2.586% during midday trading on Friday, hitting $5.991. The stock had a trading volume of 9,080 shares. Sensus Healthcare, Inc. has a 1-year low of $3.61 and a 1-year high of $6.50. The firm’s market cap is $80.81 million. The firm has a 50-day moving average price of $5.93 and a 200-day moving average price of $5.20.
Sensus Healthcare (NASDAQ:SRTS) last announced its quarterly earnings data on Thursday, August 3rd. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.14) by $0.08. The business had revenue of $4.97 million during the quarter, compared to analyst estimates of $4.50 million. Sensus Healthcare had a negative return on equity of 16.40% and a negative net margin of 13.31%. On average, equities analysts anticipate that Sensus Healthcare, Inc. will post ($0.33) EPS for the current fiscal year.
Separately, Maxim Group began coverage on Sensus Healthcare in a research report on Tuesday, June 6th. They issued a “buy” rating and a $6.50 target price for the company.
An institutional investor recently bought a new position in Sensus Healthcare stock. B. Riley Financial Inc. bought a new position in shares of Sensus Healthcare, Inc. (NASDAQ:SRTS) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 104,794 shares of the company’s stock, valued at approximately $421,000. B. Riley Financial Inc. owned about 0.77% of Sensus Healthcare at the end of the most recent reporting period. 10.46% of the stock is owned by institutional investors.
Sensus Healthcare Company Profile
Sensus Healthcare, Inc, formerly Sensus Healthcare, LLC, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy.
Receive News & Ratings for Sensus Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensus Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.